According to a study published in the Journal of the American Medical Association , patients on GLP-1 therapies experience significantly higher rates of gastrointestinal adverse events compared with non-users
Because it is a research peptide rather than an FDA-approved drug, a provider must weigh the limited human data against your situation
Beneficial skin type(s): All skin types
24-0764, approved by the Colorado Medical Institutional Review Board (COMIRB)
Amarikwa, L., Mohamed, A., Kim, S
Well, while the sublingual route would seem to be more effective in theory, research doesnt actually back it up